| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2021-09-16 | BAUPOST GROUP LLC/MA | Translate Bio, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-09-10 | FMR LLC | Translate Bio, Inc. | 245,870 | 0.3% | EDGAR |
| SC 13D | 2021-08-16 | Magnetar Financial LLC | Translate Bio, Inc. | 3,972,186 | 5.3% | EDGAR |
| SC 13D | 2021-08-12 | Sanofi | Translate Bio, Inc. | 3,684,434 | 4.9% | EDGAR |
| SC 13D/A | 2021-08-04 | BAUPOST GROUP LLC/MA | Translate Bio, Inc. | 18,044,239 | 24.0% | EDGAR |
| SC 13G/A | 2021-05-10 | FMR LLC | Translate Bio, Inc. | 9,790,249 | 13.0% | EDGAR |
| SC 13G/A | 2021-02-12 | RTW INVESTMENTS, LP | Translate Bio, Inc. | 2,978,427 | 4.0% | EDGAR |
| SC 13G/A | 2021-02-08 | FMR LLC | Translate Bio, Inc. | 6,029,561 | 8.1% | EDGAR |
| SC 13G | 2021-02-04 | Sanofi | Translate Bio, Inc. | 4,884,434 | 6.6% | EDGAR |
| SC 13G/A | 2021-02-02 | Atlas Venture Fund VIII, L.P. | Translate Bio, Inc. | 2,656,517 | 3.6% | EDGAR |
| SC 13G/A | 2021-02-01 | BlackRock Inc. | Translate Bio, Inc. | 5,440,640 | 7.3% | EDGAR |
| SC 13G/A | 2021-01-25 | TAKEDA PHARMACEUTICAL CO LTD | Translate Bio, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2020-11-10 | FMR LLC | Translate Bio, Inc. | 6,089,861 | 8.2% | EDGAR |
| SC 13D/A | 2020-08-10 | BAUPOST GROUP LLC/MA | Translate Bio, Inc. | 18,044,239 | 24.3% | EDGAR |
| SC 13D/A | 2020-05-11 | BAUPOST GROUP LLC/MA | Translate Bio, Inc. | 17,544,239 | 27.9% | EDGAR |
| SC 13D/A | 2020-02-14 | GLAXOSMITHKLINE PLC | Translate Bio, Inc. | 646,541 | 1.1% | EDGAR |
| SC 13G/A | 2020-02-14 | Omega Fund IV, L.P. | Translate Bio, Inc. | 979,179 | 1.6% | EDGAR |
| SC 13G | 2020-02-14 | RTW INVESTMENTS, LP | Translate Bio, Inc. | - | - | EDGAR |
| SC 13G/A | 2020-02-07 | FMR LLC | Translate Bio, Inc. | 8,037,605 | 13.4% | EDGAR |
| SC 13G | 2020-02-07 | BlackRock Inc. | Translate Bio, Inc. | 3,158,571 | 5.3% | EDGAR |